 Addex Therapeutics Ltd NASDAQ:ADXN Q3 2022 Results Conference Call November 11, 2022 10:00 AM ET Company Participants Tim Dyer - Co-Founder, Board Director and CEO Rob Lütjens - Head of Discovery, Biology Mikhail Kalinichev - Head of Translational Science Conference Call Participants Tim Dyer Hello everyone. Id like to thank you all for joining our Quarter Three 2022 Financial Results Conference Call. 